Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model. Johnson DM, Brasel T, Massey S, Garron T, et al. Antiviral Res 2022 Dec 16:105492. doi: 10.1016/j.antiviral.2022.105492.

Read + Share

Amedeo Smart

Independent Medical Education

Johnson DM, Brasel T, Massey S, Garron T, et al. Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model. Antiviral Res 2022 Dec 16:105492. doi: 10.1016/j.antiviral.2022.105492.
PMID: 36535309